HYCOR Announces R&D Internship Program

                    HYCOR Announces R&D Internship Program

PR Newswire

GARDEN GROVE, Calif., Dec. 6. 2012

GARDEN GROVE, Calif., Dec. 6. 2012 /PRNewswire/ -- HYCOR Biomedical, Inc., a
leading manufacturer and marketer of in vitro diagnostic products for the
global allergy, autoimmune and urinalysis markets, today announced they have
launched a paid internship program. The program provides University of
California, Irvine (UCI) students with the opportunity to gain valuable work
experience in research and development (R&D) with the potential to join
HYCOR's talented R&D team as a full time employee. HYCOR currently employs 152
people worldwide.

"HYCOR is proud to be able to bring new jobs to the Orange County community by
providing employment opportunities for UCI students currently enrolled in the
university's School of Biological Sciences/Biotechnology, Biochemistry and
Molecular Biology programs," said Dick Aderman, CEO, HYCOR. "We aim to help
students gain valuable work experience in the Healthcare R&D space and are
thankful to be able to recruit from this reputable university. We look forward
to growing this program in 2013 and creating future investments in the local

HYCOR offers UCI students a paid internship that engages them in work with
leading HYCOR scientists. The company is developing an automated analyzer and
interns will have the opportunity to assist research associates with lab tasks
around assay development. They will also have an opportunity to learn the
AGILE project management process, study modern research techniques and
experience working on a self-directed team to gain valuable and marketable
experienceto establish a competitive edge in today's job market.

HYCOR is currently recruiting applicants; students should apply at the
University of California, Irvine's Zotlink site to be considered. 

About HYCOR Biomedical, Inc.
Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro
diagnostics products. Since its founding, HYCOR has expanded its presence into
urinalysis, allergy and autoimmune products used in clinical laboratories,
hospitals and doctors' offices worldwide. Among its products, HYCOR markets
the HYTEC™, KOVA^® and AUTOSTAT™ brands. The company is focused on delivering
products that provide the highest value to clinicians through innovation,
reliability and customer service. For more information, please visit

About Linden LLC
Linden is a Chicago-based private equity firm focused exclusively on leveraged
buyouts in the healthcare and life science industries. Linden's strategy is
based upon three elements: i) healthcare and life science industry
specialization, ii) integrated private equity and operating expertise, and
iii) strategic relationships with large corporations. Linden's portfolio
includes BarrierSafe Solutions International, Behavioral Centers of America,
Corpak MedSystems, Drayer Physical Therapy Institute, HYCOR Biomedical, and
Ranir. For additional information, please visit www.lindenllc.com.

SOURCE HYCOR Biomedical, Inc.

Website: http://www.hycorbiomedical.com
Contact: Katherine Dral, +1-310-309-1029, Kdral@ccapr.com
Press spacebar to pause and continue. Press esc to stop.